Jenn Buechel
President at Delfi Diagnostics, Inc.
Jenn Buechel active positions
| Companies | Position | Start | End |
|---|---|---|---|
Delfi Diagnostics, Inc.
 Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Chief Operating Officer | - | - |
| President | 2023-02-22 | - | |
MOBILion Systems, Inc.
 MOBILion Systems, Inc. Packaged SoftwareTechnology Services MOBILion Systems, Inc. offers paradigm-shifting platform technology. It will Develop a cost effective analytical system with a small footprint, high throughput, ultra-high sensitivity and selectivity enabling use in commercial applications unattainable by conventional ion mobility separation devices. The company was founded in 2015 and is headquartered in , Chadds Ford, PA. | Director/Board Member | 2022-07-25 | - |
| Aspen Global Leadership Network | Corporate Officer/Principal | - | - |
Career history of Jenn Buechel
Training of Jenn Buechel
| Stanford University | Graduate Degree |
| Queen's University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 2 |
Operational
| Chief Operating Officer | 1 |
| President | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
MOBILion Systems, Inc.
MOBILion Systems, Inc. Packaged SoftwareTechnology Services MOBILion Systems, Inc. offers paradigm-shifting platform technology. It will Develop a cost effective analytical system with a small footprint, high throughput, ultra-high sensitivity and selectivity enabling use in commercial applications unattainable by conventional ion mobility separation devices. The company was founded in 2015 and is headquartered in , Chadds Ford, PA. | Technology Services |
| Aspen Global Leadership Network | |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Health Services |
- Stock Market
- Insiders
- Jenn Buechel
- Experience
